Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Change in Receivables (2019 - 2025)

Outset Medical (OM) has disclosed Change in Receivables for 7 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 192.08% to -$1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.8 million, a 175.32% decrease, with the full-year FY2025 number at -$3.8 million, down 175.32% from a year prior.
  • Change in Receivables was -$1.8 million for Q4 2025 at Outset Medical, up from -$2.9 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $6.3 million in Q4 2021 to a low of -$2.9 million in Q3 2025.
  • A 5-year average of $1.4 million and a median of $1.4 million in 2022 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: skyrocketed 1510.73% in 2021, then plummeted 2186.33% in 2025.
  • Outset Medical's Change in Receivables stood at $6.3 million in 2021, then fell by 11.34% to $5.6 million in 2022, then plummeted by 144.23% to -$2.5 million in 2023, then skyrocketed by 177.73% to $1.9 million in 2024, then plummeted by 192.08% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Change in Receivables are -$1.8 million (Q4 2025), -$2.9 million (Q3 2025), and -$574000.0 (Q2 2025).